Results 81 to 90 of about 10,335 (173)

Elevated lipoprotein A in acute on chronic CTEPH with cardiogenic shock: a case report

open access: yes, 2021
The natural history of most thrombi undergoes total or near total resolution, but the thrombi in chronic thromboembolic pulmonary hypertension (CTEPH) do not resolve completely and subsequently increase the pulmonary vascular resistance.
Fidencio Davalos   +4 more
core   +1 more source

Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland [PDF]

open access: yes
Objectives: Given that pulmonary arterial hypertension (PAH) and chronic thromboembolic hypertension (CTEPH) are rare yet severe subtypes of pulmonary hypertension significantly impacting patients’ lives, this study analyzed the total societal costs of ...
Christina Wennerström   +10 more
core   +2 more sources

Multicentre observational screening survey for the détection of CTEPH following PE

open access: yes, 2018
Introduction : L'hypertension pulmonaire thromboembolique (CTEPH) est une complication rare mais sévère de l'embolie pulmonaire (PE). A l'heure actuelle, il n'existe aucune stratégie recommandée pour le dépistage de la CTEPH chez le patient ayant eu une ...
COQUOZ, Nicolas
core   +1 more source

Identification of Anoikis-related potential biomarkers and therapeutic drugs in chronic thromboembolic pulmonary hypertension via bioinformatics analysis and in vitro experiment

open access: yesScientific Reports
There is growing evidence that programmed cell death plays a significant role in the pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH). Anoikis is a newly discovered type of programmed death and has garnered great attention.
Haijia Yu   +6 more
doaj   +1 more source

Serum concentrations of RAGE axis molecules in patients with CTEPH.

open access: yes, 2014
Box plot analysis of serum concentrations of sRAGE (A), esRAGE (B), S100A9 (C) and HMGB1 (D) in patients with CTEPH (n = 26) and controls (n = 33). Independent Student’s t-test was used to compare groups. RAGE receptor for advanced glycation endproducts,
Anna Megerle (625942)   +13 more
core   +1 more source

Electrocardiographic signs to differentiate between chronic thromboembolic pulmonary hypertension and intermediate-high risk acute pulmonary embolism

open access: yesScientific Reports
Acute pulmonary embolism (APE) and chronic thromboembolic pulmonary hypertension (CTEPH) both causedyspnoea and right ventricular (RV) overload, but require diff erent management.
Marcin Waligóra   +8 more
doaj   +1 more source

Baseline clinical information of patients with CTEPH (n = 53).

open access: yes, 2014
Data are presented as mean±SD.Baseline clinical information of patients with CTEPH (n = 53).
Seiichiro Sakao (515628)   +10 more
core   +1 more source

Circulating Pin1 Levels in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Case‐Control Study

open access: yesPulmonary Circulation
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but severe complication of pulmonary embolism (PE), yet its underlying mechanisms remain poorly understood.
Lynn Willems   +11 more
doaj   +1 more source

Role of Endothelin-1 and TGF-B1 in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [PDF]

open access: yes
Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease of the pulmonary vessels characterized by organized thromboembolic material and vascular remodeling of pulmonary arteries associated with pulmonary hypertension.
Asghar, Muhammad Usman
core   +1 more source

Krónikus tromboembóliás pulmonális hipertóniában (CTEPH) szenvedő betegek vizsgálata klinikai exom szekvenálással

open access: yes
A CTEPH egy – tüdőemboliát követően kialakuló – nagyon ritka, rossz prognózissal, és életveszélyes jobbkamrai elégtelenséggel járó megbetegedés. Hátterében genetikai meghatározottságot is feltételeznek, de ez napjainkig nem tisztázott.
Biró, Petra Erzsébet
core  

Home - About - Disclaimer - Privacy